PIA
XENT

Piedmont Investment Advisors’s Intersect ENT, Inc XENT Stock Holding History

Piedmont Investment Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-514
Closed -$19K – 2581
2018
Q2 		$19K Buy
+514
New +$20.2K ﹤0.01% 1606

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Piedmont Investment Advisors's XENT Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 514 shares — an estimated $19K sold.

Piedmont Investment Advisors first reported a position in XENT in Q2 2018 and held it in 1 quarter. The position peaked at $19K in Q2 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 514 Intersect ENT, Inc shares in Q3 2018, an estimated $19K.
  • Piedmont Investment Advisors first reported a position in Intersect ENT, Inc in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Intersect ENT, Inc position peaked at $19K in Q2 2018.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.